develop decellularised hBPTB grafts scaffolds that reduce the risk in developing osteoarthritis in ACL reconstructed knees.
develop decellularised hBPTB grafts scaffolds that reduce the risk in developing osteoarthritis in ACL reconstructed knees.
批准号:
2283381
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --
中文摘要
前十字韧带断裂在生活方式较活跃的年轻人群中正变得越来越普遍。据估计,仅在美国,每年就有1/3000的人发生这种情况,相当于超过10万例介入手术来恢复关节的稳定性。目前最佳的手术重建技术包括使用自体或同种异体替代前交叉韧带移植物,但这些移植物存在初始坏死、退变和结合缓慢等缺点。此外,前交叉韧带重建与骨关节炎的发生有关,研究发现前交叉韧带重建膝关节的关节炎患病率更高。克服这些缺点的工程创新包括开发和优化具有受控功能性能标准的再生替换移植物,以更好地恢复关节稳定性。脱细胞生物组织,如人骨-髌腱-骨(HBPTB)[由大学专利工艺生产]提供了一种令人兴奋的替代方法来取代受损的前交叉韧带,而没有自体移植和同种异体移植的缺点。这些移植物是从自然组织中提取的,但细胞和DNA被移除,以防止患者的“排斥”。此外,它们在制造生物过程中提供了灵活性,以定制生物力学特性以匹配不同的患者群体(年龄、性别、活动等)。然而,还需要对它们的开发、实施和性能进行进一步的研究,以优化它们的使用,防止包括骨关节炎在内的退行性变化的发生。目的与目的因此,本博士提案的目的是开发脱细胞hBPTB移植物支架,通过优化移植物制造工艺、手术实施和相关的功能评估,与工业(NHS血液和移植组织及眼科服务)和临床(矫形外科顾问医生盖伊先生)合作,开发脱细胞hBPTB移植物支架,通过优化移植物制造工艺、手术实施和相关的功能评估,降低ACL重建膝关节发生骨关节炎的风险。核心目标是:1.通过群体特异性和分层方法确定脱细胞hBTB的精确生物力学特性要求。尽管年龄和体重指数等其他参数会影响人类前交叉韧带的特性,但个体的性别仍然是与生物力学特性最相关的参数。该提案的这一部分将允许通过操纵制造生物过程,对男性和女性人口的脱细胞hBTB产品进行分层。确定正确的固定方法(例如,螺丝、悬挂装置)和在植入这些产品和优化产品/主机界面时涉及的张拉。目的:基于CT影像和生物力学测试,评价脱细胞hBTB内固定对周围骨环境原位结构特性和稳定性的影响。临床洞察力将由项目团队的外科顾问医生提供。开发工具以评估开发的产品的生物力学功能,并参照本地前交叉韧带结构制定实施策略,旨在通过获得产业合作伙伴的组织库服务来取代和当前的黄金标准替代移植物(同种移植物)。与资助机会的战略协调该提案与EPSRC为未来研究资助确定的战略主题“制造未来”中的“21世纪产品”优先领域非常一致。这项研究还涉及EPSRC“医疗保健技术”主题中的“开发未来疗法”和“优化治疗”领域。此外,在行业合作伙伴到位的情况下,翻译调查结果的机会很高,学生身份中产生的证据可以用于未来的影响案例研究。
英文摘要
BackgroundRupture of the anterior cruciate ligament (ACL) is becoming increasingly prevalent in younger populations with more active lifestyles. It has been estimated to occur at an annual rate of 1 in 3000 in the US alone, translating to over 100,000 interventional surgeries to restore joint stability. Current best practice surgical reconstruction techniques involve using autologous or allogeneic replacement ACL grafts, but these have drawbacks including initial necrosis, degeneration and slow incorporation. Additionally, ACL reconstruction has been associated with the onset of osteoarthritis with studies finding a greater prevalence of arthritis in ACL reconstructed knees. Engineering innovations to combat these drawbacks include the development and optimisation of regenerative replacement grafts with controlled functional performance criteria to better restore joint stability. Decellularised biological tissues such as human bone-patellar tendon-bone (hBPTB) [produced by University patented processes] offer an exciting alternative approach to replace damaged ACLs without the disadvantages of autografts and allografts. These grafts are derived from natural tissue but the cells and DNA are removed to prevent 'rejection' by the patient. Furthermore, they offer flexibility in their manufacturing bioprocess to tailor the biomechanical properties to match different patient populations (age, gender, activity etc.). However, further research in their development, implementation and performance is required in order to optimise their use and prevent the onset of degenerative changes including osteoarthritis.Aims & objectivesThe aim of this PhD proposal is therefore to develop decellularised hBPTB grafts scaffolds that reduce the risk in developing osteoarthritis in ACL reconstructed knees through optimisation of the graft manufacturing processes, surgical implementation and associated functional assessment, in collaboration with industrial (NHS Blood and Transplant Tissue and Eye Services) and clinical (Mr Guy, consultant orthopaedic surgeon) partners. The core objectives are:1. Determining the precision biomechanical property requirements of decellularised hBTBs through a population specific and stratified approach. Although other parameters such as age and body mass index affect the properties of human ACLs, the sex of the individual remains the parameter most strongly associated with biomechanical properties. This segment of the proposal will allow for the stratification of decelluarised hBTB products for male and female populations by manipulation of the manufacturing bioprocess.2. Identifying the correct fixation methods (e.g. screws, suspension devices) and tensioning involved in implanting these products and optimising the product/host interface. To assess the effects of decellularised hBTB fixation on the in-situ structural properties of the surrounding bone environment based on CT imaging and the stability using biomechanical testing. Clinical insight will be provided by the consultant surgeon on the project team.3. Developing tools to assess the biomechanical function of the developed product and implementation strategy with reference to the native ACL structure it is intended to replace and current gold standard replacement grafts (allografts) through access to the industrial partner's tissue banking service. Strategic alignment with funding opportunitiesThe proposal is exceptionally well aligned to the "21st Century Products" priority area within the strategic theme of "Manufacturing the Future" identified by the EPSRC for future research grant funding. The research also addresses the "Developing Future Therapies" and "Optimising treatment" areas within the EPSRC's "Healthcare Technologies" theme. Furthermore, opportunities to translate findings are high with an industrial partner in place and evidence generated in the studentship can be utilised for future impact case studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金